IV, Fenoldopam Two
IV fenoldopam is a short‑acting selective D1‑receptor agonist used for rapid blood pressure reduction.
Indicaciones de Uso
Used for hypertensive emergencies, especially with acute kidney injury, where it provides controlled BP reduction while increasing renal blood flow (AHA/ACC 2025) 1 [Level I evidence]. Clinically lowers BP dose‑dependently and is an alternative to nitroprusside (JAMA RCT) 2 [Level II evidence]. Not effective for preventing/treating established AKI in large RCTs (JAMA 2014) 3 [Level I evidence].
Información y Precauciones
Start at 0.1–0.3 mcg/kg/min IV, titrating every 15 minutes; expect rapid BP fall (5–15 min) but monitor closely for hypotension, which increases significantly in RCTs (26% vs 15%, P=0.001) 1 [Level I evidence]. Avoid in glaucoma, intracranial hypertension, or sulfite allergy per AHA/ACC guidance 2 [Level I evidence]. Renal protection is inconsistent, with large RCTs showing no reduction in AKI or RRT 3 [Level I evidence].